(Q53665843)

17 May 2018

title

Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. (English)

1 reference

17 May 2018

0 references

0 references

0 references

1 reference

Treasa Nic Suibhne

1

1 reference

17 May 2018

Gerry Cox

2

1 reference

17 May 2018

Martin Healy

3

1 reference

17 May 2018

Colm O'Morain

4

1 reference

17 May 2018

Maria O'Sullivan

5

1 reference

17 May 2018

publication date

25 September 2011

1 reference

17 May 2018

Journal of Crohn's and Colitis

published in

1 reference

17 May 2018

volume

6

1 reference

17 May 2018

issue

2

1 reference

17 May 2018

page(s)

182-188

1 reference

17 May 2018

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Vitamin D status and cytokine levels in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Risk factors for vitamin D deficiency in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

The frequency of vitamin D deficiency in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Vitamin D status in children and young adults with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Worldwide status of vitamin D nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Which circulating level of 25-hydroxyvitamin D is appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

The Vitamin D requirement in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

Estimation of the dietary requirement for vitamin D in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2011.08.002

10.1016/J.CROHNS.2011.08.002

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018